Nejentsev et al. hypothesized that frequent variants of IFIH1 are selected to efficiently fight viral infection whereas rare variants disrupting the native IFIH1 function may protect from T1D risk. This evidence concerns the gene IFIH1 and type 1 diabetes mellitus.